Work

What are the bleeding risks associated with ticagrelor compared to clopidogrel in the treatment of peripheral artery disease?

Year: 2026
Type: article
Abstract: Current evidence indicates no significant difference in major bleeding risk between ticagrelor and clopidogrel in patients with peripheral artery disease, though ticagrelor may have a higher incidence of minor bleeding.
Author: Tripdatabase
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7230088046
FWCI:
Cites:
Cited by:
Related to: 10